Lunit Opens “Lunit INSIGHT for Mammography” for Public Access

Lunit’s newest medical AI solution to breast cancer; open for free trial on the web

 

  • Detects malignant lesions with an unprecedented level of accuracy at 97%
  • Instantly delivers analysis results: providing location info and abnormality scores

 

Thank you for your interest in Lunit.

We are pleased to announce today the public unveiling of our newest medical AI solution for breast cancer, Lunit INSIGHT for Mammography.

Lunit INSIGHT for Mammography is a diagnostic support tool that accurately detects malignant lesions with 97% accuracy. It provides location information of detected lesions in heatmaps and shows abnormality scores that reflect the probability of malignancy. Our clinical study has shown positive results in augmenting the interpretive performance of radiologists in reading mammograms, and the use of our product is expected to increase cancer detection rate while decreasing the recall rate.

You can CLICK HERE to upload breast images and get instant analysis from our AI.

We will also be providing a demo at RSNA this year. (Booth #7561 North)

As many of you may already be aware, last November, we’ve launched our first product, Lunit INSIGHT for Chest Radiography. Since then, it has analyzed more than 1.5 million cases from more than 70 countries around the world. We thank you all for your support.

We would appreciate your continued interest and support in our journey in “Perfecting Intelligence, Transforming Medicine”. Thank you.

(Lunit INSIGHT for Mammography is intended to aid in the detection, localization, and characterization of suspicious areas for breast cancer on FFDM images, and has not been regulatory approved (e.g., FDA) for clinical use.)

Sincerely,

Lunit team

---CLICK HERE to upload breast images and get instant AI analysis from Lunit INSIGHT----

About Lunit

Perfecting Intelligence. Transforming Medicine.

Lunit, abbreviated from “learning unit,” is a medical AI software company devoted to developing advanced medical image analytics and data-driven imaging biomarkers via cutting-edge deep learning technology.

Founded in 2013, Lunit has been internationally acknowledged for its advanced, state-of-the-art technology and its application in medical images. It has been named by CB Insights as one of “AI 100” startups transforming healthcare industry.

Lunit's technology has been recognized at international competitions such as ImageNet (5th place, 2015), TUPAC 2016 (1st place), and Camelyon 2017 (1st place), surpassing top companies like Google, IBM, and Microsoft. Lunit is based in Seoul, South Korea.

Lunit’s mission is to empower physicians with clinically actionable insights that foster accurate and cost-efficient diagnosis and treatment through unprecedented AI-powered imaging biomarkers with cutting-edge, world-leading accuracy.

Lunit
6th floor, 175 Yeoksam-ro, Gangnam-gu,
Seoul, South Korea

서울시 강남구 역삼로 175 6층 (역삼동, 현승빌딩)